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ABSTRACT		
Transforming	 growth	 factor	 β	 (TGF-β)	 is	 one	 of	 the	 major	 inducers	 of	 epithelial	 to	
mesenchymal	 transition	 (EMT),	 a	 crucial	 program	 that	 plays	 a	 critical	 role	 in	 promoting	
carcinoma’s	 metastasis	 formation.	 MicroRNAs-143	 and	 -145,	 which	 are	 both	 TGF-β	 direct	
transcriptional	targets,	are	essential	for	the	differentiation	of	vascular	smooth	muscle	cells	(VSMC)	
during	embryogenesis,	a	TGF-β-dependent	process	reminiscent	of	EMT.	Their	role	in	adult	tissues	
is	 however	 less	 well	 defined	 and	 even	 ambiguous,	 since	 their	 expression	 was	 correlated	 both	
positively	and	negatively	with	tumor	progression.	
Here	we	show	that	high	expression	of	both	miRs-143	and	-145	 in	mouse	mammary	tumor	
cells	expressing	constitutively	active	STAT3	(S3C)	 is	at	 least	partly	responsible	for	their	disrupted	
cell-cell	 junctions.	 Additionally,	 miR-143	 appears	 to	 play	 a	 unique	 role	 in	 tumorigenesis	 by	
enhancing	 cell	 migration	 in	 vitro	 and	 extravasation	 in	 vivo	 while	 impairing	 anchorage-
independent	growth,	which	may	explain	the	contradictory	reports	about	its	role	in	tumors.		
Accordingly,	we	demonstrate	 that	overexpression	of	either	miRNA	 in	 the	non-transformed	
mammary	epithelial	NMuMG	cells	 leads	to	upregulation	of	EMT	markers	and	 increased	motility.	
This	 correlates	 with	 enhanced	 basal	 and	 TGF-β-induced	 activity	 of	 SMAD	 transcription	 factors,	
suggesting	that	promotion	of	TGF-β	mediated	EMT	occurs	via	a	positive	feedback	loop.	Moreover,	
pervasive	transcriptome	perturbations	consistent	with	the	described	phenotype	were	observed.	In	
particular,	the	expression	of	several	transcription	factors	 involved	in	the	mitogenic	responses,	of	
MAPK	 family	 members	 and,	 importantly,	 of	 several	 tight	 junction	 proteins	 and	 the	 SMAD	 co-
repressor	TGIF	was	significantly	reduced.		
Our	 results	 provide	 important	mechanistic	 insight	 into	 the	 non-redundant	 role	 played	 by	
miRs-143	 and	 -145	 in	 EMT-related	 processes	 in	 both	 transformed	 and	 non-transformed	 cells,	
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suggesting	 moreover	 that	 their	 expression	 must	 be	 finely	 coordinated	 to	 warrant	 optimal	
migration/invasion	while	not	interfering	with	cell	growth.	
		
INTRODUCTION	 	
Metastases	at	distant	sites	represent	the	main	cause	of	death	for	cancer	patients,	underlining	the	
importance	 of	 unravelling	 the	 molecular	 mechanisms	 that	 govern	 cancer	 progression	 to	
metastasis.	Local	 invasion	 is	an	essential	step	 in	the	metastasis	process,	and	 it	 is	controlled	by	a	
coordinated	 series	of	 cellular	and	molecular	events	known	as	EMT	 (1),	which	endows	cells	with	
enhanced	migration	and	invasion	potential,	resistance	to	anoikis	and	production	of	extra	cellular	
matrix	 components(2),	 facilitating	 the	 invasion	 at	 both	 local	 and	 distant	 tissues.	 Successful	
colonization	 of	 the	 target	 tissue	 occurs	 thanks	 to	 the	 inverse	 process,	 i.e.	 mesenchymal	 to	
epithelial	transition,	 leading	to	the	formation	of	metastases	with	features	of	the	tumor/tissue	of	
origin	 (3).	 EMT	 main	 outcome	 is	 the	 acquisition	 of	 a	 spindle-like	 morphology	 due	 to	 the	
remodeling	of	the	actin	cytoskeleton	to	form	stress	fibers,	a	progressive	loss	of	epithelial-specific	
adhesion	 molecules,	 like	 E-cadherin,	 Zonula	 Occludens-1	 (ZO1)	 and	 Integrin	 β-1,	 and	 the	
expression	 of	mesenchymal-specific	 adhesion	 and	 cytoskeletal	 proteins	 such	 as	 N-cadherin	 and	
Vimentin	 (2).	 This	 process	 is	 orchestrated	 by	 the	 upregulation	 of	 a	 number	 of	 EMT-inducing	
transcription	factors	and	the	modulation	of	specific	miRNAs	(4-6).		
TGF-β,	a	main	inducer	of	EMT,	plays	a	dual	role	in	cancer	progression.	While	its	cytostatic	activity	
initially	 inhibits	 proliferation	 of	 tumor	 cells,	 EMT	 induction	 favours	 progression	 to	 metastatic	
diseases.	 Via	 its	 complex	 and	 highly	 modulated	 signaling	 network,	 TGF-β	 leads	 to	 the	
phosphorylation	 and	 activation	 of	 SMAD	 factors	 that	 in	 turn	 contribute	 to	 the	 activation	 or	
repression	of	hundreds	of	 targets,	both	coding	and	non-coding	 (3,	7).	Among	others,	TGF-β	was	
shown	 to	 strongly	 induce	 the	 expression	 of	 miRNAs-143	 and	 -145,	 which	 are	 clustered	 at	 an	
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intergenic	 locus	and	subjected	to	coordinated	transcriptional	regulation	 (8,	9).	Both	were	shown	
to	play	a	role	in	the	differentiation	of	VSMC	during	development	(8,	10),	and	their	expression	was	
sufficient	to	induce	the	differentiation	of	multipotent	neural	crest	stem	cells	into	VSMCs,	a	TGF-β-
dependent	process	considered	as	a	form	of	EMT	(8,	10,	11).	In	adult	tissues,	inactivation	of	both	
miRNAs	 lead	 to	 impaired	 neointima	 formation	 upon	 vascular	 injury,	 due	 to	 disorganized	 actin	
stress	fibers	and	reduced	migratory	ability	of	smooth	muscle	cells.		
Despite	 related	 biological	 functions,	 these	 two	 miRNAs	 do	 not	 share	 sequence	 similarity	 and	
mostly	recognize	different	sets	of	target	genes	(11).	They	are	both	considered	as	oncosuppressors,	
since	they	are	frequently	downregulated	in	epithelial	tumors	such	as	colon	(12),	prostate	(13)	and	
ovary	 (14,	 15)	 cancer,	 as	 well	 as	 in	 B-cell	 malignancies	 (16).	 Additionally,	 their	 locus	 is	 often	
deleted	 in	tumors	(17),	and	they	both	have	been	shown	to	exert	anti-proliferative	activities	 (18-
22).	 	Recently	however,	several	reports	have	challenged	this	concept	for	both	miR-143	and	miR-
145,	whose	 expression	was	 shown	 to	 correlate	with	 invasion,	 disease	 grade	 and	 progression	 in	
specific	 types	 of	 tumors	 (23-26),	 suggesting	 that	 their	 role	 in	 cancer	may	 vary	 according	 to	 cell	
type	and	tumor	stage,	similar	to	what	has	been	described	for	TGF-β	itself	(27).	
Here,	we	show	that	miRNAs-143	and	 -145	contribute	 to	 the	 invasive	phenotype	of	cells	derived	
from	STAT3C/NeuT	transgenic	mice	mammary	tumors.	These	tumors,	which	develop	thanks	to	the	
ectopic	expression	of	the	rat	Neu	oncogene	in	the	mammary	epithelium,	are	more	aggressive	and	
invasive	when	mice	also	carry	a	constitutively	active	form	of	the	transcription	factor	STAT3	(S3C)	
(28).	Moreover,	we	show	that	miR-143	and	-145	overexpression	triggers	EMT	features	in	the	non-
transformed	NMuMG	mammary	epithelial	cells,	eliciting	global	gene	expression	changes.	
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	RESULTS	
1.	MiRNAs-143	and	-145	contribute	to	the	EMT	phenotype	of	S3C	mammary	tumor	cells.		
S3C	cell	lines	from	mammary	tumors	of	NeuT-STAT3C	transgenic	mice,	which	express	the	MMTV-
driven	rat	NeuT	oncogene	in	the	mammary	epithelium	and	carry	a	knocked-in	constitutively	active	
form	 of	 the	 transcription	 factor	 STAT3,	 display	 enhanced	 migration,	 invasion	 and	 in	 vivo	
tumorigenic	 potential	 correlating	with	 disorganized	 cell-cell	 contacts,	 including	 delocalization	 of	
the	 tight	 junctions	 component	 ZO1	 (28).	 Accordingly,	 these	 cells	 also	 exhibit	 strongly	 increased	
expression	 of	 the	 EMT	 markers	 N-cadherin,	 Snail	 and	 α-SMA,	 and	 slight	 decreased	 ZO1	 levels	
(Figure	1a),	suggesting	transition	towards	a	mesenchymal	status.	In	search	for	potential	mediators	
of	this	phenotype,	we	observed	that	miRNAs-143	and	-145	are	dramatically	upregulated	in	STAT3C	
cells	(Figure	1b	and	Supplementary	Figures	S1a	and	b).	To	assess	the	potential	contribution	of	miR-
143	and	-145	to	the	EMT	status	of	S3C	cells,	we	decided	to	interfere	with	their	activity	by	means	of	
sponge	 constructs.	 Lentiviral	 vectors	 were	 engineered	 to	 carry	 a	 GFP	 expression	 cassette	
displaying	multimerized	miR-143	 or	miR-145	 target	 sites	 in	 their	 3’UTR	 regions	 (Supplementary	
Figures	S2a	and	b).	Upon	stable	transduction	of	S3C	cells,	both	sponge	vectors	caused	a	reduction	
of	GFP	levels,	demonstrating	their	efficacy,	and	could	revert	the	cell	junction	defects	of	S3C	cells,	
triggering	relocalization	of	both	β-catenin	and	ZO1	to	 the	cell	membrane	and	 leading	 to	a	more	
organized,	epithelial-like	morphology	(Figure	1c).	Accordingly,	both	miR-143	and	miR-145	sponges	
triggered	 a	 decrease	 in	 N-cadherin	 and	 Snail	 and	 an	 increase	 in	 ZO1	 levels	 (Figure	 1d).	 These	
changes	correlated	with	impaired	migration	as	measured	by	Transwell	assay	(Figure	1e).	Therefore,	
both	miR-143	and	-145	appear	to	be	involved	in	regulating	cell-cell	contacts	leading,	in	the	case	of	
miR-143,	 to	 significantly	 enhanced	 in	 vitro	 cell	 migration.	We	 thus	 decided	 to	 extend	miR-143	
analysis	to	in	vivo	assays.	
2.	Interference	with	miRNA-143	activity	impairs	in	vivo	cell	extravasation.	
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The	effects	of	miR-143	on	in	vivo	tumorigenic	potential	were	assessed	by	comparing	the	ability	of	
sponged	 or	 control	 S3C	 cells	 to	 extravasate	 into	 the	 lung	 parenchyma	 upon	 i.v.	 injection.	 Cells	
were	labelled	with	a	fluorescent	dye	(CMRA)	allowing	cell	tracking	and	injected	in	the	tail	vein	of	
NSG	 immunocompromised	mice,	 followed	 by	 evaluation	 of	 the	 number	 of	 cells	 in	 the	 tissue	 at	
different	time	points.	Confirming	equivalent	loading,	comparable	numbers	of	both	cell	types	were	
observed	 in	 the	 lungs	 15	 minutes	 after	 injection,	 predominantly	 still	 associated	 to	 the	 blood	
vessels	(Figure	2a,	upper	panel).	Quantification	after	24	hours	showed	significantly	less	cells	in	the	
lung	 parenchyma	 of	 mice	 injected	 with	 sponged	 S3C	 cells	 (Figure	 2a,	 lower	 panel).	 Thus,	
interfering	with	miR-143	activity	in	S3C	cells	impairs	extravasation	in	vivo.	Despite	this,	sp-miR143	
S3C	cells	could	give	rise	to	an	equivalent	number	of	metastases	as	compared	with	the	control	GFP	
cells	(Figure	2b),	suggesting	that	a	higher	percentage	of	sp-miR143	S3C	extravasated	cells	are	able	
to	 survive	 and	 proliferate	 in	 the	 lung	 parenchyma.	 Accordingly,	 miR-143	 inhibition	 significantly	
enhanced	 anchorage-independent	 growth,	 as	 shown	 by	 the	 increased	 number	 and	 size	 of	 sp-
miR143	S3C	soft	agar	colonies	(Figure	2c)	and	despite	normal	proliferation	rates	of	adherent	cells	
and	 equivalent	 sensitivity	 to	 anoikis	 (Supplementary	 Figures	 S3a	 and	 b).	 Enhanced	 anchorage-
independent	proliferation	could	 therefore	counterbalance	 the	 impaired	extravasation	 leading	 to	
unaltered	 metastasis	 number.	 These	 results	 suggest	 a	 dual	 role	 in	 the	 metastatic	 process	 for	
miRNA-143,	which	on	one	hand	enhances	cell	extravasation	while	on	the	other	hand	impairs	the	
proliferation	of	extravasated	cells.	
3.	MiRNAs-143	 and	 -145	 expression	 in	mammary	 epithelial	 cells	 and	 in	mammary	 tumor	 cell	
lines	is	induced	by	TGF-β		
To	confirm	the	involvement	of	miR-143	and	-145	in	the	induction	of	EMT,	we	tested	their	activity	
in	the	epithelial	mammary	gland	Namru	Murine	Mammary	Gland	(NMuMG)	cell	line	model	of	TGF-
β-induced	 EMT	 (29).	 Indeed,	 treatment	 of	 NMuMG	 cells	 with	 TGF-β	 for	 3	 days	 triggered	 a	
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transition	 to	 a	mesenchymal-like	morphology	 and	 the	 formation	of	 abundant	 actin	 stress	 fibers	
(Figure	3a).	As	expected,	TGF-β	treatment	elicited	SMAD2	phosphorylation	and	reciprocal	changes	
in	the	expression	of	N-cadherin	and	E-cadherin,	particularly	evident	at	72	hours	(Figure	3b).	Under	
these	conditions,	we	also	observed	a	strong	upregulation	of	the	expression	of	both	miR-143	and	-
145,	already	evident	after	24	hours	of	stimulation	and	peaking	at	72	hours	(Figures	3c	and	d).	Thus,	
miRNAs-143	and	-145	are	bona	fide	TGF-β	targets	in	NMuMG	cells,	and	their	induction	profiles	are	
consistent	with	them	playing	a	role	in	TGF-β-mediated	EMT.	
4.	 	 Overexpression	 of	miRNAs-143	 and	 -145	 in	 NMuMG	 cells	 suppresses	 ZO1	 expression	 and	
induces	EMT.	
To	assess	their	role	in	TGF-β-induced	EMT,	both	miRNA-143	and	-145	were	stably	over-expressed	
together	 with	 a	 RFP	 cassette	 in	 NMuMG	 cells	 by	 means	 of	 lentiviral	 vectors	 (Supplementary	
Figures	S4a	and	b).	Overexpression	of	either	miRNA	triggered	a	transition	in	cell	morphology	and	
the	 formation	 of	 long,	 filamentous	 pseudopods,	 while	 cell	 proliferation	 was	 not	 altered	 as	
compared	to	control	cells	transduced	with	an	empty	vector	(Figures	4a	and	b).	Importantly,	both	
miRNAs	 also	 triggered	 the	 upregulation	 of	 the	 N-cadherin	 and	 Snail	 EMT	 markers,	 a	 slight	
reduction	of	 E-cadherin	 (Figure	4c),	 and	a	dramatic	downregulation	of	 ZO1	at	both	protein	 and	
mRNA	level	(Figures	4c	and	d).	These	changes	correlated	with	significantly	increased	motility	in	a	
wound	 healing	 assay	 (Figure	 4e).	 Thus,	 ectopic	 expression	 of	 both	 miRNAs	 can	 independently	
confer	 EMT	 features	 to	normal	mammary	 gland	 cells.	 The	enhanced	 cell	motility	observed	 is	 at	
least	partly	due	 to	 the	 suppression	of	ZO1	expression,	 since	 shRNA-mediated	ZO1	silencing	was	
sufficient	to	enhance	the	migration	of	NMuMG	cells	(Figures	4f	and	g).	
5.	miRNAs-143	and	-145	overexpression	leads	to	increased	SMAD-mediated	transcription.	
The	 above	 results	 suggest	 that	mir-143	 and	miR-145	may	 impact	 on	 TGF-β/SMAD	 signaling.	 To	
verify	 this,	 we	 generated	 a	 SMAD-luciferase	 reporter	 construct,	 which	 was	 dose-dependently	
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activated	by	TGF-β	upon	transient	transfection	in	NMuMG	cells	(Supplementary	Figures	S5a	and	b).	
Interestingly,	 basal	 luciferase	 activity	 of	 the	 SMAD	 reporter	 was	 3.2	 and	 3.6	 fold	 higher,	
respectively,	 in	 NMuMG	 cell	 overexpressing	 miRNA-143	 or	 miRNA-145	 as	 compared	 to	 empty	
vector	cells	(Figure	5a).	This	was	apparently	independent	from	the	expression	or	phosphorylation	
levels	of	SMAD	family	members,	which	were	not	significantly	altered	(Supplementary	Figures	S5c	
and	 d).	 miRNAs	 overexpression	 was	 also	 able	 to	 amplify	 TGF-β-induced	 SMAD-dependent	
transcription,	 since	 TGF-β	 treatment	 elicited	 about	 a	 three-fold	 higher	 luciferase	 induction	 in	
overexpressing	 cells	 with	 respect	 to	 controls	 (Figure	 5a).	 Conversely,	 sponge-mediated	
interference	 with	 the	 activity	 of	 either	 miRNA	 (Supplementary	 Figures	 S2a	 and	 b)	 significantly	
reduced	 TGF-β-induced	 reporter	 activity	 (Figure	 5b),	 supporting	 the	 idea	 that	 TGF-β-dependent	
upregulation	 of	 miRNAs-143	 and	 -145	 contributes	 to	 the	 activation	 of	 SMAD-mediated	
transcription	in	a	classical	feed	forward	loop.		
6.	Overexpression	of	miRs-143	and	145	strongly	perturbs	the	transcriptome	of	NMuMG	cells		
As	 shown	above,	miRNAs	overexpressing	NMuMG	cells	 display	 remarkably	 similar	 alterations	 in	
the	expression	of	relevant	EMT-related	genes,	and	in	particular	downregulation	of	E-cadherin	and	
ZO1	expression,	neither	of	which	is	however	predicted	as	a	common	miRNA	target	by	TargetScan	
and	MREdictor	 softwares	 (30).	We	 thus	 decided	 to	 assess	 the	 transcriptome	 alterations	 of	 the	
overexpressing	cells	by	RNA	sequence	analysis.	In	keeping	with	their	superimposable	phenotypes,	
miR-143	 and	 miR-145	 overexpressing	 NMuMG	 cells	 displayed	 very	 similar	 mRNA	 expression	
profiles,	 with	 1391	 genes	 downregulated	 and	 1006	 genes	 upregulated	 by	 at	 least	 2	 fold	 (and	
adjusted	 p-value	 <0.05)	 as	 compared	 with	 control	 cells	 (Supplementary	 Table	 1).	 Importantly,	
predicted	 targets	 of	 both	 miRNAs	 were	 significantly	 enriched	 among	 the	 down-,	 but	 not	 the	
upregulated	 genes,	 (Figures	 6a	 and	 b,	 Supplementary	 Figures	 S6a	 and	 b).	 Nevertheless,	 the	
number	of	downmodulated	genes	greatly	exceeded	the	number	of	common	miRNA	target	mRNAs,	
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sixty	according	to	MREdictor	(Supplementary	Table	2).	Such	a	strong	transcriptome	perturbation	
may	stem	from	the	downregulation	of	key	transcription	factors	such	as	Fos	(c-Fos),	Fosb,	Creb,	ATF,	
Elk4,	Srf,	and	several	Egr	and	C/EBP	family	members	(Supplementary	Figures	S7a-c).	Among	these,	
Creb1	is	a	putative	direct	target	of	both	miRNAs	(Supplementary	Table	2),	and	its	modulation	was	
also	confirmed	at	the	protein	level	along	with	that	of	c-Fos	and	Egr1	(Figure	6c).		
KEGG	analysis	of	downregulated	genes	revealed	significant	disruption	of	the	MAP	kinase	pathway,	
and	 in	 particular	 strongly	 reduced	 levels	 of	 Map3k2	 (MEKK2),	 Map4K5	 and	 Mapk8ip3	 kinases	
(Figure	6d,	Supplementary	Figures	S6b	and	S7a-c).	Downregulation	of	MEKK2	kinase,	predicted	as	
a	common	target	of	both	miRNAs,	correlated	with	significantly	decreased	phosphorylation	of	both	
ERK1/2	and	MEK1/2	(Figures	6e	and	f).			
Importantly,	sequencing	data	not	only	confirmed	downregulation	of	the	Tjp1	(ZO1)	mRNA	
(Figures	4c	and	d,	Supplementary	Figures	S7a-c)	but	also	unveiled	a	strong	reduction	 in	 its	 tight	
junctions	partners	Tjp3	(ZO3)	and	Occludin,	thus	strengthening	the	role	of	miRNAs-143	and	-145	in	
disrupting	 cell-cell	 junctions	 (Supplementary	 Figure	 S7c).	 Finally,	 we	 also	 observed	 significant	
downregulation	 of	 the	well	 know	 SMAD	 transcriptional	 corepressor	 Tgif1	 (TGIF)	 (Figure	 6c	 and	
Supplementary	 Figure	 S7c),	 which	 may	 well	 explain	 the	 enhanced	 TGF-β-induced	 transcription	
observed	in	the	miRNA	over-expressing	cells.		
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DISCUSSION	
MiRNAs	 are	well-known	 players	 in	 tumor	 transformation	 and	 progression,	 being	 able	 to	
exert	 both	 tumor	 suppressive	 and	 promoting	 roles	 (31-33).	 However,	 the	 definition	 of	 their	
specific	functions	often	escapes	rigid	classifications,	due	to	cell-	and	stage-specific	effects	such	as	
differential	expression,	regulation	and	accessibility	of	their	putative	targets.	miRNAs-143	and	-145	
are	no	exception	to	this	rule.	Indeed,	both	were	initially	classified	as	tumor-suppressors	based	on	
both	 expression	 analysis	 of	 tumors	 and	 cell	 lines	 and	 functional	 experiments	 (34-36).	However,	
several	 recent	 publications	 suggested	 that	 their	 expression	 can	 also	 correlate	 with	 tumor	
progression,	metastasis	and	recurrence	in	colorectal	cancer,	esophageal	tumors	and	HBV-related	
hepatocellular	 carcinoma,	 where	 their	 functional	 role	 is	 confirmed	 by	 in	 vitro	 and	 in	 vivo	
experiments	 (23-25).	 Additionally,	 expression	 of	 both	miRNAs	was	 found	 to	 be	much	 higher	 in	
mesenchymal	 cells,	 including	 the	 tumor	 stroma,	 than	 in	 epithelial	 cells,	 suggesting	 that	 the	
assessment	of	their	expression	in	whole	tumor	biopsies	may	be	misleading	(35).		
Our	 data	 demonstrate	 that	 miRNAs-143	 and	 -145	 contribute	 to	 promote	 EMT	 and	 cell	
migration	in	both	transformed	and	non-transformed	mammary	gland	cells,	consistent	with	a	pro-
metastatic,	 rather	 than	 oncosuppressive,	 role.	 This	 function	 is	 consistent	 with	 the	 phenotype	
observed	 in	adult	 smooth	muscle	 cells	 from	miR-143	and	miR-145	null	mice.	These	cells	display	
defective	 rearrangement	of	 the	actin	 cytoskeleton	and	 impaired	migration	upon	vascular	 injury,	
consequently	failing	to	give	origin	to	the	scar	tissue	known	as	neointima	(10,	11,	37).	Thus,	despite	
a	 general	 consensus	 that	 the	 expression	of	miRNAs-143	 and	 -145	 triggers	 the	differentiation	of	
embryonal	stem	and	precursor	cells	(38),	correlating	with	proliferation	arrest	as	also	observed	in	
several	tumor	models	(18-20,	22)	,	their	physiological	function	in	adult	tissues	appears	to	be	less	
well	 defined.	 Particularly	 intriguing	 is	 the	 observation	 that	 interference	 with	 miR-143	 in	 the	
aggressive	 breast	 tumor	 S3C	 cells	 significantly	 reduced	 their	 ability	 to	 extravasate	 into	 the	 lung	
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parenchyma	 while	 increasing	 the	 proliferation	 of	 extravasated	 cells.	 Thus,	 miRNA-143	 activity	
appears	indeed	to	enhance	the	ability	of	cancer	cells	to	invade	distant	tissues,	but	it	likely	has	to	
be	downregulated	after	extravasation	in	order	to	ensure	optimal	proliferation	and	colonization.		
TGF-β	 is	 the	major	 inducer	of	EMT,	both	during	development	and	 in	adult	cells	 including	
tumors	 (3).	Our	data	 suggest	 that	both	miRNAs-143	and	 -145	are	 involved	 in	mediating	at	 least	
some	 of	 the	 EMT	 features	 triggered	 by	 TGF-β	 treatment	 in	 normal	 mammary	 epithelial	 cells.	
Indeed,	both	miRNAs	are	bona	fide	SMAD-dependent	TGF-β	transcriptional	targets	(9),	and	their	
ectopic	 expression	 is	 sufficient	 to	 modulate	 several	 EMT	 markers	 and	 enhance	 cell	 migration	
independently	of	cytokine	treatment.	This	effect	is	at	least	partly	due	to	the	ability	of	both	miRNAs	
to	enhance	basal	and	TGF-β	induced	SMAD-dependent	transcription.		
RNA	 sequencing	 analysis	 has	 revealed	 that	 overexpression	 of	 either	 miRNA	 pervasively	
perturbs	the	transcriptome,	in	keeping	with	the	knowledge	that	miRNAs	can	directly	and	indirectly	
modulate	 thousands	of	 target	genes,	partly	by	 regulating	a	high	number	of	 transcription	 factors	
(39,	40).	Also	in	our	cells	transcription	factors	such	as	Srf	and	Elk4,	the	AP-1	family	members	c-Fos,	
Fosb	and	ATF3	and	several	Egr	family	members	are	highly	represented	among	the	downregulated	
genes.	Although	none	of	these	is	predicted	as	a	direct	miR-143	and/or	miR-145	target,	several	are	
transcriptionally	regulated	by	Creb1	(41),	which	is	instead	a	putative	direct	target	of	both	miRNAs	
and	is	also	downregulated	in	the	overexpressing	cells	(see	also	the	scheme	in	Fig.	6g).	On	the	other	
hand,	Creb1	is	the	main	transcriptional	activator	of	Occludin,	and	is	predicted	to	play	a	role	in	the	
transcription	 of	 Tjp1/ZO1	 as	 well,	 whose	 promoter	 additionally	 carries	 several	 functional	 AP-1	
binding	sites	(42,	43)	.	Thus,	the	reduced	levels	of	Creb1	and	of	AP-1	family	members	may	explain	
the	observed	downregulation	of	the	mRNAs	encoding	for	the	tight	junction	proteins	ZO1,	Occludin	
and	 possibly	 also	 ZO3.	 In	 turn,	 altered	 expression	 of	 tight	 junction	 proteins	 can	 at	 least	 partly	
account	for	the	enhanced	migration	elicited	by	the	two	miRNAs	in	NMuMG	cells,	as	confirmed	by	
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the	enhanced	motility	of	ZO1-silenced	NMuMG	cells.	
In	agreement	with	previous	work	demonstrating	that	miRNAs-143	and	-145	can	modulate	
MAPK	 signaling	 by	 targeting	 several	 genes	 in	 the	 signaling	 cascade	 (44),	 our	 results	 revealed	
significant	 disruption	 of	 the	 MAPK	 pathway.	 Indeed,	 downregulation	 of	 the	 putative	 direct	
common	 target	 MEKK2	 (and	 possibly	 of	 Map4k5	 and	 Mapk8ip3)	 correlates	 with	 decreased	
phosphorylation	 of	 both	 ERK1/2	 and	MEK1/2,	without	 affecting	 their	 protein	 levels.	 This	 can	 in	
turn	 contribute	 to	 the	 observed	 reduced	 expression	 of	 the	 AP-1-	 and	 Srf-family	 transcription	
factors.	Although	the	activity	of	MAP	kinases	is	generally	considered	as	a	marker	of	proliferation	
and	 tumor	 transformation,	 the	 many	 feedback	 interactions	 with	 other	 important	 signaling	
pathways	forbid	simplistic	interpretations.	For	example,	Kim	et	al	reported	that	miR26a-mediated	
downregulation	of	MEKK2	enhances	the	growth	of	glioblastoma	cells	both	in	vitro	and	in	vivo	(45).	
On	 the	 other	 hand,	 reduced	 basal	 ERK	 activation	 may	 well	 explain	 the	 impaired	 anchorage-
independent	 growth	 of	 the	 S3C	 cell.	 In	 this	 vein,	 ERK-mediated	 phosphorylation	 is	 known	 to	
stabilize	TGIF,	a	well-known	co-repressor	of	SMADs	transcriptional	activities,	thus	interfering	with	
TGF-β-mediated	 functions	 (46-48).	 Although	 Tgif1	mRNA	 is	 not	 predicted	 to	 be	 a	 direct	miRNA	
target	 and	 its	 transcriptional	 regulation	 is	 poorly	 characterized,	 the	 observed	 reduced	 TGIF	
expression	may	very	well	explain	the	enhanced	SMAD-mediated	transcription,	and	the	consequent	
increased	migration	and	expression	of	EMT	markers	elicited	by	miR-143	and	-145	overexpression.	
	 In	conclusion,	our	results	clearly	demonstrate	that	microRNAs	-143	and	-145	enhance	EMT	
features	of	both	transformed	and	normal	mammary	epithelial	cells,	 increasing	motility	but	(miR-
143)	 impairing	anchorage-independent	cell	proliferation.	These	effects	occur	via	both	direct	and	
indirect	regulation	of	the	MAPK	pathway	and	of	transcription	factors	impacting	on	the	expression	
of	EMT	markers	and	on	TGF-β/SMADs	transcriptional	activity	 (Fig.	6g).	 	MicroRNAs	expression	 is	
known	to	be	tightly	regulated	in	time	and	space	under	physiological	conditions,	in	agreement	with	
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their	 ability	 to	 fine-tune	 gene	 expression.	 The	 evidences	 here	 reported	 support	 this	 idea,	
suggesting	 that	 the	 consequences	 of	 therapeutic	 approaches	 aimed	 at	 interfering	with	miRNAs	
activity	have	to	be	carefully	evaluated.	
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MATERIALS	AND	METHODS	
Ethics	 statement:	 The	present	 investigation	has	been	 conducted	 in	 accordance	with	 the	ethical	
standards	and	according	to	the	Declaration	of	Helsinki	and	to	national	and	international	guidelines,	
and	has	been	approved	by	the	Faculty	Ethical	Committee	and	by	the	Italian	Ministry	of	Health.		
Animal	 treatments.	 12	 weeks	 old	 NSG	 (NOD.Cg-Prkdcscid	Il2rgtm1Wjl/SzJ)	 female	 mice	 were	
maintained	in	the	pathogen	free	transgenic	unit	of	the	Molecular	Biotechnology	Center,	under	a	
12	hour	light-dark	cycle	and	provided	food	and	water	ad	libitum.		
Cell	 lines.	Murine	mammary	tumor	cell	lines	(WT	and	S3C)	were	isolated	from	MMTV-NeuT	mice	
and	cultured	as	previously	described	(49).	WT1	and	S3C1	cells	are	used	throughout	the	paper	and	
referred	 to	 as	 WT,	 S3C.	 NMuMG	 cells	 were	 kindly	 provided	 by	 Prof.	 C.	 Watson	 (University	 of	
Cambridge,	UK),	and	were	maintained	as	previously	described	(29).	hTGF-β1	(Peprotech,	Rocky	Hill,	
NJ,	USA)	was	used	at	a	final	concentration	of	10ng/ml	for	the	indicated	lengths	of	time.		
Plasmid	 construction	 and	 generation	 of	 stable	 cell	 lines.	 The	 genomic	 regions	 containing	 the	
murine	 pre-miRNA-143	 or	 -145	were	 amplified	 by	 PCR	 and	 cloned	 under	 the	 control	 of	 a	 CMV	
promoter	 into	 the	 pLemiR-tRFP	 vector	 (GE	 Healthcare,	 Little	 Chalfon,	 UK)	 to	 obtain	 the	 over-
miR143	and	over-miR145	 lentiviral	 constructs.	 For	 the	preparation	of	 the	miR-143	 and	miR-145	
sponges,	 292	 nts	 long	 sequences	 (Supplementary	 Table	 3),	 containing	 eight	 bulged	 target	 sites	
specific	 for	miR-143	or	miR-145	 interrupted	by	 linkers,	were	designed	as	described	 in	Krol	et	al.	
(50),	 synthesized	by	DNA2.0	 (Newark,	 CA,	USA)	 and	 cloned	 in	 the	 3’UTR	of	 a	GFP	 cassette	 in	 a	
pLenti-CMV-GFP-Puro	vector	(Addgene,	Cambridge,	MA,	USA),	generating	the	sp-miR143	and	sp-
miR145	vectors.	The	pLemiR-tRFP	and	pLenti-CMV-GFP-Puro	empty	vectors	were	used	as	controls.	
All	 stable	 cell	 lines	 were	 generated	 via	 lentiviral	 infection.	 Lentiviral	 particles	 were	 produced	
according	to	Trono’s	 lab	protocol	 (http://tronolab.epfl.ch).	Supernatant	was	harvested	48h	post-
transfection,	filtered	with	0.45	mm	filters,	diluted	and	used	to	transduce	cells,	in	the	presence	of	
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Polybrene	 (Sigma	 Aldrich,	 Saint	 Louis,	 MI,	 USA).	 For	 the	 transduction	 of	 S3C	 cells,	 lentiviral	
particles	 were	 concentrated	 by	 supernatant	 ultracentrifugation	 (5x104g	 for	 2h	 at	 4°C),	
resuspended	in	PBS	and	then	used	to	transduce	cells	in	low	adhesion	conditions.	To	generate	the	
SMAD	 reporter	 a	 DNA	 oligonucleotide	 sequence	 containing	 three	 SMAD3-4	 binding	 sites	 (51)	
(Supplementary	Table	3)	was	cloned	upstream	of	the	TATA	box	in	the	pTA-Luc	vector	(Addgene).	
The	SMAD	reporter	was	co-transfected	with	a	pRL-TK	Renilla	plasmid	in	NMuMG	cells	by	means	of	
Lipofectamine	2000	 (Thermo	Fisher	 Scientific,	Waltham,	MA,	USA),	 according	 to	manufacturer’s	
instructions.	 Firefly	 and	Renilla	 Luciferase	 activities	were	measured	48h	upon	 transfection,	with	
the	Dual-Glo	Luciferase	Assay	system	(Promega,	Madison,	WI,	USA)	and	a	96	microplates	GloMax	
luminometer	(Promega).	
Western	blots.	Total	protein	extracts	were	obtained	and	Western	blots	performed	as	described	in	
Schiavone	et	al	 (52).	The	following	antibodies	were	used:	N-cadherin	(Abcam,	Cambridge,	UK);	E-
cadherin,	 β-catenin	 (BD,	 Franklin	 Lakes,	 NJ,	 USA);	 Snail,	 pSMAD2,	 SMAD2,	 pSMAD3-1,	 SMAD3,	
pERK1/2,	ERK1/2,	pMEK1/2,	MEK1/2,	Creb1	(Cell	Signaling	Technology,	Danvers,	MA,	USA);	α-SMA,	
α-tubulin	(Sigma	Aldrich);	ZO1	(Thermo	Fisher	Scientific);	SMAD4,	Egr1,	c-Fos,	MEKK2,	TGIF,	Actin	
(Santa	 Cruz	 Biotechnology,	 Santa	 Cruz,	 CA,	 USA);	 GAPDH	 (Merck-Millipore);	 Vinculin	 and	 GFP	
(home	made).	Western	 blot	 chemilumiscent	 signals	 were	 acquired	 with	 a	 ChemidocTouch	 and	
analysed	with	the	ImageLab	software	(BioRad).	All	blots	were	repeated	at	least	three	times.	One	
representative	image	is	shown.	
RNA	 isolation	and	qRT-PCR	 for	miRNA	or	mRNA	detection.	Total	RNA	was	isolated	using	TRIzol	
Reagent	(Thermo	Fisher	Scientific).	qRT-PCR	reactions	for	miRNA	detection	were	performed	with	
the	 indicated	 TaqMan	 MicroRNA	 Assay	 (Thermo	 Fisher	 Scientific)	 on	 total	 RNA,	 according	 to	
manufacturer’s	 instructions,	 and	 normalized	 on	 U6	 RNA	 levels.	 mRNAs	 expression	 levels	 were	
evaluated	 by	 means	 of	 qRT-PCR	 assays	 based	 on	 the	 Universal	 Probe	 Library	 (Roche,	 Basel,	
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Switzerland)	 technology,	 normalized	 on	 18s	 RNA	 levels.	 Primers	 and	 probes	 used	 are	 listed	 in	
Supplementary	Table	4.	The	relative	expression	levels	between	samples	were	calculated	using	the	
comparative	 delta	 CT	 (threshold	 cycle	 number)	 method	 (2-ΔΔCT)	 with	 a	 control	 sample	 as	 the	
reference	point.	
Immunofluorescence.	Cells	plated	on	glass	coverslips	were	treated	as	 reported	 in	Barbieri	et	al.	
(28),	incubated	with	primary	antibodies	at	room	temperature	for	1	hour,	followed	by	anti-rabbit	or	
anti-mouse	 conjugated	 AlexaFluor	 568	 antibody	 (Thermo	 Fisher	 Scientific)	 or	 phalloidin-FITC	
(Sigma	 Aldrich)	 and	 then	 by	 Hoescht-dye.	 An	 Axiovert	 200M	 Zeiss	 microscope	 or	 the	 Axio-
Observer-Z1	Zeiss	microscope	with	the	ApoTome	system	for	optical	sectioning	were	used.	Images	
were	 acquired	 with	 the	 MetaMorph	 software	 (Molecular	 Devices,	 Sunnivale,	 CA,	 USA)	 or	 the	
AxioVision	release	4.6.3	software	(Carl	Zeiss,	Oberkochen,	Germany),	respectively.	
Scratch	 assay	 and	 Transwell	 migration	 assays.	 In	 vitro	 scratch	 assays	 were	 performed	 as	
described	by	Liang	et	al.	 (53),	with	some	modifications.	 In	brief,	cells	were	grown	to	confluence	
and	 starved	 overnight	 with	 0%	 FCS.	 Two	 hours	 before	 the	 scratch,	 cells	 were	 treated	 with	 10	
μg/ml	mitomycin	C	(Sigma	Aldrich).	The	cell	monolayer	was	scraped	in	a	straight	line	with	a	pipet	
tip	in	order	to	create	a	linear	wound.	Debris	were	removed	by	washing	the	cells	with	PBS	and	then	
replaced	 with	 complete	 medium	 plus	 mitomycin	 C.	 Photographs	 of	 the	 wounds	 (10	 fields	 per	
experiment)	 were	 taken	with	 a	 phase-contrast	 Olympus	 IX70	microscope.	 For	 each	 image	 cells	
migrated	into	the	original	wound	were	measured,	normalized	to	the	original	wound	area,	then	the	
control	 condition	 is	 imposed	 as	 reference	 and	other	 conditions	 expressed	 as	 relative.	 Transwell	
assays	were	performed	as	described	in	Barbieri	et	al.	 (28),	after	24h	of	migration	pictures	of	the	
cells	on	the	lower	surface	were	taken	and	then	quantified	with	the	ImageJ	software.		
In	 vivo	 extravasation	 and	 lung	 metastases.	 For	 extravasation	 experiments,	 5x105	 cells	 were	
labelled	 with	 CellTracker	 Orange	 CMRA	 (Thermo	 Fisher	 Scientific),	 resuspended	 in	 PBS	 and	
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injected	 into	 the	 tail	 vein	 of	 NSG	 mice.	 After	 15min	 or	 24h,	 mice	 were	 sacrificed	 and	 4%	
paraformaldehyde	was	 injected	 into	 the	 trachea.	 Total	 lungs	were	 dissected	 and	 photographed	
using	a	Leica	MZ16F	fluorescence	stereomicroscope.	Red-fluorescent	(CMRA)	cells	were	counted	
using	 the	 ImageJ	 software.	 For	 long	 term	metastases,	 1x105	 cells	were	 resuspended	 in	PBS	and	
injected	 into	 the	 tail	 vein	 of	 7-week-old	 female	NSG	mice.	 After	 3	weeks	mice	were	 sacrificed,	
lungs	 collected	 and	 fixed	 for	 paraffin	 embedding,	 semiserial	 sections	 at	 100	µm	 intervals	were	
stained	with	H&E	and	neoplastic	lesions	quantified	with	the	ImageJ	software.	
Anchorage-independent	 growth	assay	 and	anoikis.	1	x	104	cells	were	resuspended	 in	complete	
DMEM	containing	0.3%	low	gelling	agarose	(Sigma	Aldrich)	and	seeded	in	plates	containing	a	layer	
of	solid	0.6%	agar	(Sigma	Aldrich).	After	3	weeks	colonies	were	stained	with	nitroblue	tetrazolium	
(Sigma	 Aldrich),	 photographed	 with	 a	 Nikon	 SMZ1000	 stereomicroscope	 and	 colonies	 were	
counted	using	the	ImageJ	Software.	For	suspension-induced	anoikis,	confluent	adherent	cells	were	
detached	 from	 regular	 culture	 plates	 with	 EDTA,	 seeded	 onto	 poly-HEMA	 coated	 plates	 (poly-
HEMA,	 10	 mg/ml,	 Sigma	 Aldrich),	 and	 cultured	 for	 24	 hours	 in	 complete	 culture	 medium.	
Apoptosis	 was	 assessed	 by	 annexin	 V	 staining	 (BD)	 with	 aFACScalibur	 flow	 citometer	 (BD)	 and	
CellQuest	software.	Positive	cells	are	expressed	as	percentage	of	the	total.	
RNA-Seq	 library	 preparation.	For	RNA-Seq	 library	preparation,	approximately	2	μg	of	 total	RNA	
from	 the	 different	 NMuMG	 cell	 lines	 was	 subjected	 to	 poly(A)	 selection,	 and	 libraries	 were	
prepared	 using	 the	 TruSeq	 RNA	 Sample	 Prep	 Kit	 (Illumina,	 San	 Diego,	 CA,	 USA)	 following	 the	
manufacturer’s	instructions.	Sequencing	was	performed	on	the	Illumina	NextSeq	500	platform.	
RNA-Seq	data	analysis.	Illumina	BCL	files	were	demultiplexed	to	FastQ	format	using	the	bcl2fastq	
tool	 from	 Illumina.	 Prior	 to	 mapping,	 the	 reads	 quality	 was	 estimated	 using	 the	 FastQC	 tool	
v0.10.1	 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).	 The	 nucleotide	 positions	
with	a	quality	score	below	30	(Phred33	scale)	were	trimmed	using	the	fastx_trimmer	tool	from	the	
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FASTX	Toolkit	(http://hannonlab.cshl.edu/fastx_toolkit/).	After	 low-quality	position	trimming,	the	
reads	in	which	sequencing	continued	through	the	3’	adapter	sequence	were	subjected	to	adapter	
clipping	using	the	fastx_clipper	tool	from	the	FASTX	Toolkit,	and	the	reads	shorter	than	35	nt	were	
discarded.	 Reads	 were	 mapped	 to	 mouse	 mm9	 assembly	 using	 TopHat	 v2	
(http://tophat.cbcb.umd.edu/,	 parameters:	 --bowtie1	 -a	 5	 --library-type	 fr-unstranded).	 Genes	
counts	 were	 computed	 using	 the	 htseq-count	 tool	 from	 the	 HTSeq	 package	
(http://www.huber.embl.de/HTSeq/doc/overview.html)	 and	 differential	 expression	 analysis	 was	
performed	using	R	and	DESeq2	package	
	(http://www.bioconductor.org/packages/devel/bioc/html/DESeq2.html).	 Genes	with	 adjusted	 p-
value	<	0.05	and	abs(log2(Fold	Change))	>=	1	were	considered	significantly	modulated,	and	kept	
for	downstream	analyses.	
MiRNA	 targets	 prediction.	 For	microRNA	 targets	 prediction,	 we	 used	 either	MREdictor	 (30)	 or	
TargetScan	algorithms.	Annotated	3’-UTRs	for	up-	or	downregulated	genes	in	either	miR-143a	or	
miR-145a	overexpressing	cells,	were	scanned	for	strict	miRNA	targets	(8mer,	7mer-m8,	and	7mer-
A1).	The	significance	of	the	measured	overlaps	were	calculated	using	a	hypergeometric	test.	
Statistical	analyses.	Unless	otherwise	noted,	data	were	analyzed	by	one-way	ANOVA	or	Student’s	
t-test,	using	the	Prism	(GraphPad	software).	For	qRT-PCR	statistical	analyses	were	performed	on	2-
ΔΔCT	values.		
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FIGURE	LEGENDS	
Figure	 1.	MicroRNAs-143	 and	 -145	modulate	 cell-cell	 contacts	 and	migration	of	 S3C	 cells.	 a,b)	
S3C	and	WT	cells	were	analyzed	(a)	by	Western	blot	with	the	indicated	antibodies,	or	(b)	by	qRT-
PCR	to	assess	miRNAs	expression	levels.	Mean	±	S.E.M.	of	expression	values	relative	to	WT	cells.	
N=3.	c-e)	 sp-miR143,	 sp-miR-145	or	empty	vector	 control	 S3C	cells	were	analyzed	by	 (c)	 IF	with	
indicated	 antibodies	 (scale	 bar=20μm),	 (d)	 Western	 blot	 with	 indicated	 antibodies	 and	 (e)	 by	
Transwell	 assay.	 Data	 are	mean	 ±	 S.E.M.	 of	 the	 area	 covered	 by	migrated	 cells,	 relative	 to	 the	
empty	vector	control.	N=3.	
	
Figure	2.	MicroRNA-143	 inhibition	 reduces	extravasation	but	not	metastases.	 (a)	Fluorescently	
labelled	sp-miR143	or	empty	vector	S3C	cells	were	 injected	 i.v.	 into	NSG	mice	 (scale	bar=1mm),	
followed	 by	 analysis	 of	 the	 lungs	 at	 the	 indicated	 times.	 Quantification	 at	 24	 hours	 (mean	 cell	
number	±	S.E.M)	is	shown	in	the		histogram.	N=7.	(b)	Lung	metastases	were	assessed	three	weeks	
after	 cells	 injection	 by	 H&E	 staining	 of	 whole	 lung	 sections	 (left	 panel,	 scale	 bar=5mm).	
Quantification	is	shown	in	the	histogram	and	normalized	to	the	lung	area	(mean±	S.E.M).	N=4.	(c)	
Soft	 agar	 cultures	 are	 shown	 on	 the	 left	 panel,	 scale	 bar=5mm).	 The	 histograms	 show	
quantification	of		colony	number	and	size	(mean	±	S.E.M).	N=3.		
	
Figure	3.	MicroRNAs-143	and	-145	are	induced	by	TGF-β	treatment.		
NMuMG	cells	either	untreated	(NT)	or	treated	with	TGF-β	for	the	indicated	time	were	analyzed	by	
a)	 phase	 contrast	 and	 immunofluorescence	 (scale	 bar=30μm),	 b)	 Western	 blot	 on	 whole	 cell	
extracts	 with	 the	 indicated	 antibody,	 and	 (c,	 d)	 qRT-PCR	 assessing	 miR-143	 and	 miR-145	
expression.	Data	are	mean	±	S.E.M.	of	expression	values	relative	to	untreated	cells.	N=3.	
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Figure	4.	MicroRNAs-143	and	 -145	overexpression	 in	NMuMG	cells	alters	cell	morphology	and	
enhances	 cell	motility.	a-e)	NMuMG	cells	 overexpressing	miR-143,	miR-145	or	 transduced	with	
the	control	empty	vector	were	analyzed	by:	a)	Fluorescence	with	phalloidin-FITC,	showing	changes	
in	the	actin	cytoskeleton	(scale	bar=20μm).	b)	Cell	proliferation	assay	(mean	cell	counts	±	S.E.M;	
N=3),	c)	Western	blot	on	total	cell	lysates,	d)	qRT-PCR	measuring	ZO1	mRNA	(mean	±	S.E.M.	of	the	
expression	values	relative	to	empty	vector,	N=3)	and	e)	Scratch	assay	in	a	confluent	cell	monolayer,	
measured	 after	 24	 hours.	 The	 fluorescent	 images	 show	 the	 RFP-expressing	 cells	 (scale	 bar=	
100μm),	 while	 the	 histogram	 describes	 the	 %	 of	 wound	 closure	 (see	 Materials	 and	 Methods	
section),	 relative	 to	 empty	 vector	 control.	 N=3.	 f,	 g)	 NMuMG	 cells	were	 transduced	with	 three	
different	ZO1	shRNA	vectors	(shZO1	#1,	2,	3),	or	with	a		scrambled	control	(shSCR),	and	analyzed	
by	Western	blot	to	assess	silencing	(f),	and	by	scratch	assay	(g).	The	histogram	describes	the	%	of	
wound	closure	relative	to	shSCR	control	at	24	hours.	N=3.		
	
Figure	5.	MicroRNAs-143	and	-145	enhance	SMAD-dependent	transcription.	Luciferase	activity	of	
a	SMAD-reporter	sensor	was	assessed	in	NMuMG	cells	stimulated	or	not	with	TGF-β	for	24h	either	
(a)	 stably	 overexpressing	 the	miRNAs,	 or	 (b)	 stably	 trasduced	with	miR-143	 or	miR-145	 sponge	
vectors.		Luciferase	activity	(mean	±	S.E.M.)	was	calculated	relative	to	untreated	empty	vector	cells,	
upon	Renilla	normalization.	N=3.	
	
Figure	6.	Overexpression	of	microRNA-143	or	-145	profoundly	perturbates	the	transcriptome	of	
NMuMG	 cells.	 Venn	 diagrams	 representing	 statistically	 significant	 enrichment	 of	 MREdictor	
predicted	 targets	 of	 (a)	 miR-143	 or	 (b)	 miR-145	 among	 the	 genes	 downregulated	 by	
overexpression	 of	 both	miRNAs	 in	NMuMG	 cells.	 c-f)	 Cell	 lysates	 from	 the	 indicated	 cells	were	
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analyzed	 with	 the	 indicated	 antibodies.	 g)	 The	 scheme	 shows	 a	 model	 explaining	 the	 EMT	
phenotype	triggered	by	overexpression	of	either	microRNA.		
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Supplementary	  Figure	  1.	  miRNAs-­‐143	  and	   -­‐145	  expression	   levels	   in	  WT	  and	  S3C	  NeuT	  derived	  
cell	   lines.	  a-­‐b)	  miRNA	  expression	  levels	  were	  measured	  by	  qRT-­‐PCR	  in	  two	  independent	  cell	  lines	  
derived	   from	   WT	   and	   S3C	   NeuT	   tumors	   (WT1,	   WT3,	   S3C1,	   S3C3).	   Data	   are	   mean	   ±	   S.E.M.	   of	  
expression	  values	  relative	  to	  WT1	  cells.	  N=3.	  
	  
	  
	  
	  
	  
	  
	  
	  
Supplementary	   Figure	   2.	   Generation	   and	   testing	   of	   microRNAs	   sponge	   vectors.	   a)	   Schematic	  
representation	   of	   pLenti	   CMV	   GFP	   Puro	   construct	   carrying	   multimerized	   miR-­‐143	   or	   miR-­‐145	  
binding	   sites	   in	   the	   GFP	   gene	   3‘UTR.	   b)	   HEK293	   cells	   were	   transiently	   transfected	  with	   sponge	  
vectors	  specific	  for	  miR-­‐143	  (sp-­‐miR143),	  miR-­‐145	  (sp-­‐miR145)	  or	  an	  empty	  vector,	  together	  with	  
the	   indicated	  miRNA	  precursors.	  GFP	  expression	   levels	  were	  measured	  by	  Western	  blot	  on	  total	  
cell	   lysates.	   Numbers	   below	   the	   lanes	   indicate	   the	   densitometric	   analysis	   of	   the	   GFP	   band,	  
normalized	  to	  Vinculin	  and	  relative	  to	  the	  values	  obtained	  with	  empty	  vector	  transfected	  cells.	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Supplementary	  Figure	  3.	  Characterization	  of	  S3C	  cells	  transduced	  with	  the	  miR-­‐143	  or	  miR-­‐145	  
sponge	  vectors.	  a)	  Proliferation	  of	  S3C	  cells	  stably	  transduced	  with	  the	  indicated	  sponge	  vectors	  
was	  assessed	  for	  four	  days	  after	  plating,	  by	  measuring	  the	  Optical	  Density	  (OD)	  of	  Crystal	  violet-­‐
stained	   cells	   after	   solubilization	   in	  acetic	   acid.	  Results	   are	   shown	  as	  mean	  OD	  ±	  S.E.M.	  of	   three	  
independent	  experiments	  performed	  in	  triplicate.	  N=3.	  b)	  Annexin	  V	  positive	  cells	  were	  measured	  
by	   flow-­‐cytometry	   upon	   24h	   of	   plating	   on	   poly-­‐HEMA	   treated	   dishes.	   Results	   are	   expressed	   as	  
mean	  ±	  S.E.M.	  of	  Annexin	  V+	  cells	  from	  three	  independent	  experiments,	  relative	  to	  empty	  vector	  
control	  cells.	  N=3.	  	  
	  
	  
	  
	  
	  
	  
	  
Supplementary	   Figure	   4.	   Generation	   and	   testing	   of	   microRNAs	   overexpressing	   vectors.	   a)	  
Schematic	   representation	   of	   the	   lentiviral	   vector	   pLemir,	   engineered	   to	   express	   the	   precursor	  
sequences	   of	   either	   miR-­‐143	   or	   miR-­‐145.	   b)	   Expression	   levels	   of	   the	   indicated	   miRNAs	   were	  
evaluated	  by	  qRT-­‐PCR	   in	  NMuMG	  cells	   transduced	  with	   the	   indicated	  overexpressing	   vectors	  or	  
with	  the	  empty	  control	  vector.	  Results	  are	  shown	  as	  mean	  ±	  S.E.M.	  of	  expression	  values	  relative	  to	  
empty	  vector	  control.	  N=3.	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Supplementary	   Figure	   5.	   Generation	   of	   the	   SMAD	   reporter	   vector	   and	   SMADs	   activity	   in	  
NMuMG	  overexpressing	   cells.	  a)	  Schematic	   representation	  of	   the	  SMAD-­‐reporter	  vector,	  where	  
three	  SMAD	  binding	  elements	   (SBE)	  were	   inserted	  upstream	  of	   the	  minimal	  TK	  promoter	   in	   the	  
pTA-­‐Luciferase	  vector.	  b)	  Luciferase	  activity	  of	  NMuMG	  cells	  transfected	  with	  the	  SMAD-­‐reporter	  
vector	  and	  stimulated	   for	  24h	  with	   the	   indicated	  doses	  of	  TGF-­‐β.	   	  Results	  are	  shown	  as	  mean	  ±	  
S.E.M.	  of	  luciferase	  values	  after	  normalization	  to	  Renilla	  luciferase	  and	  relative	  to	  untreated	  cells.	  
c)	  Western	  blot	  assessing	  	  phosphorylated	  and	  total	  protein	  levels	  of	  the	  indicated	  SMAD	  proteins	  
in	   NMuMG	   overexpressing	   cells	   under	   basal	   conditions.	   d)	   Western	   blot	   assessing	  	  
phosphorylation	   levels	   of	   the	   indicated	   SMAD	   proteins	   in	   NMuMG	   overexpressing	   cells	   upon	  
treatment	  with	  10ng/ml	  TGF-­‐β	  for	  the	  indicated	  time.	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Supplementary	   Figure	   6.	   TargetScan	   predicted	   miRNAs	   target	   are	   significantly	   enriched	   in	  
dowregulated	   mRNAs.	   The	   Venn	   diagrams	   represent	   statistically	   significant	   enrichment	   of	  
TargetScan	   predicted	   targets	   of	   miR-­‐143	   (a)	   or	   miR-­‐145	   (b)	   among	   the	   genes	   commonly	  
downregulated	  by	  overexpression	  of	  either	  miRNA	  in	  NMuMG	  cells.	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Supplementary	  Figure	  7.	  qRT-­‐PCR	  validation	  of	  RNA	  sequencing	  data.	  The	  expression	  of	  a	  subset	  
of	   mRNAs	   identified	   as	   down-­‐modulated	   by	   RNA	   sequencing	   was	   validated	   by	   qRT-­‐PCR.	   The	  
indicated	   mRNAs	   were	   measured	   from	   total	   RNA	   of	   the	   indicated	   NMuMG	   cells.	   The	   mRNA	  
encoding	   for	   (a)	   Transcription	   factors,	   (b)	   MAP	   kinases,	   (c)	   TGFβ	   inhibitors	   and	   tight	   junction	  
proteins	  were	  analyzed.	  Results	  are	  shown	  as	  mean	  ±	  S.E.M.	  of	  expression	  values	  relative	  to	  empty	  
vector,	  after	  normalization	  to	  beta-­‐actin	  RNA.	  *=P<0.05,	  **=P<0.01;***=P<0.001,	  N=4.	  	  
